We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

NanoVibronix Inc (NAOV) USD0.001

Sell:$0.96 Buy:$1.00 Change: $0.0016 (0.16%)
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
Sell:$0.96
Buy:$1.00
Change: $0.0016 (0.16%)
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
Sell:$0.96
Buy:$1.00
Change: $0.0016 (0.16%)
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus.

Contact details

Address:
525 Executive Blvd
ELMSFORD
10523
United States
Telephone:
+1 (914) 2333004
Website:
https://nanovibronix.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NAOV
ISIN:
US63008J6038
Market cap:
$2.04 million
Shares in issue:
2.05 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Brian Murphy
    Chief Executive Officer, Director
  • Stephen Brown
    Chief Financial Officer
  • Harold Jacob
    Chief Medical Officer, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.